{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:42:40Z","timestamp":1778694160767,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":45,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ahjo.2022.100158","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T02:17:35Z","timestamp":1655777855000},"page":"100158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinical use of ivabradine in the acute coronary syndrome: A systematic review and narrative synthesis of current evidence"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-8146","authenticated-orcid":false,"given":"Josip A.","family":"Borovac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Poklepovic Pericic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marin","family":"Vidak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"D'Amario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino","family":"Miric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duska","family":"Glavas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josko","family":"Bozic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahjo.2022.100158_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pharmthera.2005.01.005","article-title":"Physiology and pharmacology of the cardiac pacemaker (\u201cfunny\u201d) current","volume":"107","author":"Baruscotti","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ahjo.2022.100158_bb0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40265-016-0567-2","article-title":"Ivabradine: cardioprotection by and beyond heart rate reduction","volume":"76","author":"Heusch","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ahjo.2022.100158_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijcard.2017.02.046","article-title":"Ivabradine in acute coronary syndromes: protection beyond heart rate lowering","volume":"236","author":"Niccoli","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ahjo.2022.100158_bb0020","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ahjo.2022.100158_bb0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ahjo.2022.100158_bb0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ahjo.2022.100158_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000725","article-title":"Role of ivabradine in management of stable angina in patients with different clinical profiles","volume":"5","author":"Kaski","year":"2018","journal-title":"Open Heart"},{"key":"10.1016\/j.ahjo.2022.100158_bb0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahjo.2022.100158_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40261-016-0424-9","article-title":"Ivabradine in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a preliminary randomized prospective study","volume":"36","author":"Barilla","year":"2016","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ahjo.2022.100158_bb0050","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cardfail.2009.05.013","article-title":"Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings","volume":"15","author":"Fasullo","year":"2009","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ahjo.2022.100158_bb0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2012.04.076","article-title":"Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study","volume":"158","author":"Dominguez-Rodriguez","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ahjo.2022.100158_bb0060","first-page":"270","article-title":"Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study","volume":"2","author":"Steg","year":"2013","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.ahjo.2022.100158_bb0065","first-page":"1441","article-title":"A clinical study evaluating the effect of ivabradine on inflammation in patients with non ST-segment elevation acute coronary syndromes","volume":"7","author":"Adel","year":"2016","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.ahjo.2022.100158_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejccm.2015.12.003","article-title":"The effect of ivabradine on long term prevention of major adverse cardiac events in acute coronary syndrome using high-sensitivity C-reactive protein level","volume":"3","author":"Fouad Abdel Latif","year":"2015","journal-title":"Egypt.J. Crit. Care Med."},{"key":"10.1016\/j.ahjo.2022.100158_bb0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.26502\/fccm.92920159","article-title":"Value of ivabradine in patients with anterior ST-elevation myocardial infarction: the VIVA-STEMI study","volume":"4","author":"Rezq","year":"2020","journal-title":"Cardiol. Cardiovasc. Med."},{"key":"10.1016\/j.ahjo.2022.100158_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12266","article-title":"Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-\"Expanding arena for ivabradine\"","volume":"35","author":"Priti","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ahjo.2022.100158_bb0085","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.18410\/jebmh\/2019\/647","article-title":"Comparison study of effect of ivabradine versus Beta blockers in early Management of Acute Coronary Syndrome with left ventricular systolic dysfunction in a tertiary Care Hospital of West Bengal","volume":"6","author":"De","year":"2019","journal-title":"J. Evid. Based. Med. Healthc"},{"key":"10.1016\/j.ahjo.2022.100158_bb0090","article-title":"Effect of early use of ivabradine on left ventricular remodeling after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a pilot test","volume":"2","author":"Xu","year":"2021","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"10.1016\/j.ahjo.2022.100158_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.acvd.2013.12.001","article-title":"Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: a pilot study","volume":"107","author":"Gerbaud","year":"2014","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ahjo.2022.100158_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0033-0620(93)90022-6","article-title":"The role of heart rate in myocardial ischemia and infarction: implications of myocardial perfusion-contraction matching","volume":"36","author":"Indolfi","year":"1993","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.ahjo.2022.100158_bb0105","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1093\/eurheartj\/sum029","article-title":"The role of heart rate and the benefits of heart rate reduction in acute myocardial ischaemia","volume":"9","author":"Heusch","year":"2007","journal-title":"Eur. Heart J. Supp."},{"key":"10.1016\/j.ahjo.2022.100158_bb0110","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.bjp.0707673","article-title":"Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents","volume":"153","author":"Heusch","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ahjo.2022.100158_bb0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000362086","article-title":"Ivabradine: heart rate and left ventricular function","volume":"128","author":"Ferrari","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.ahjo.2022.100158_bb0120","first-page":"149","article-title":"Heart rate at admission is a predictor of in-hospital mortality in patients with acute coronary syndromes: results from 58 european hospitals: the european hospital benchmarking by outcomes in acute coronary syndrome processes study","volume":"7","author":"Jensen","year":"2018","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.ahjo.2022.100158_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010855","article-title":"Discharge heart rate after hospitalization for myocardial infarction and long-term mortality in 2 US registries","volume":"8","author":"Alapati","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ahjo.2022.100158_bb0130","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005371","article-title":"The relationship between heart rate and mortality of patients with acute coronary syndromes in the coronary intervention era: meta-analysis","volume":"95","author":"Xu","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.ahjo.2022.100158_bb0135","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ahjo.2022.100158_bb0140","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehn337","article-title":"Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction","volume":"29","author":"Heusch","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahjo.2022.100158_bb0145","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/eurheartj\/ehp554","article-title":"Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12\/12.6 expression","volume":"31","author":"Couvreur","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahjo.2022.100158_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000073933","article-title":"A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction","volume":"100","author":"Manz","year":"2003","journal-title":"Cardiology"},{"key":"10.1016\/j.ahjo.2022.100158_bb0155","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","article-title":"Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy","volume":"32","author":"Tardif","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahjo.2022.100158_bb0160","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.jacc.2016.08.036","article-title":"Adaptive immunity dysregulation in acute coronary syndromes: from cellular and molecular basis to clinical implications","volume":"68","author":"Flego","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2022.100158_bb0165","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/CIRCRESAHA.114.302699","article-title":"Inflammation and its resolution as determinants of acute coronary syndromes","volume":"114","author":"Libby","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ahjo.2022.100158_bb0170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fphar.2016.00408","article-title":"The protective effects of ivabradine in preventing progression from viral myocarditis to dilated cardiomyopathy","volume":"7","author":"Yue-Chun","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ahjo.2022.100158_bb0175","article-title":"Ivabradine prevents low shear stress induced endothelial inflammation and oxidative stress via mTOR\/eNOS pathway","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602222000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602222000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:29:13Z","timestamp":1763000953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602222000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":35,"alternative-id":["S2666602222000751"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2022.100158","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical use of ivabradine in the acute coronary syndrome: A systematic review and narrative synthesis of current evidence","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2022.100158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100158"}}